Spain · Delayed Price · Currency is EUR Making Science Group Statistics
Total Valuation
BME:MAKS has a market cap or net worth of EUR 68.68 million. The enterprise value is 59.33 million.
| Market Cap | 68.68M |
| Enterprise Value | 59.33M |
Important Dates
The next estimated earnings date is Thursday, April 16, 2026.
| Earnings Date | Apr 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:MAKS has 9.04 million shares outstanding. The number of shares has increased by 6.97% in one year.
| Current Share Class | 9.04M |
| Shares Outstanding | 9.04M |
| Shares Change (YoY) | +6.97% |
| Shares Change (QoQ) | -1.04% |
| Owned by Insiders (%) | 6.21% |
| Owned by Institutions (%) | 3.54% |
| Float | 4.14M |
Valuation Ratios
The trailing PE ratio is 2.74.
| PE Ratio | 2.74 |
| Forward PE | n/a |
| PS Ratio | 0.20 |
| PB Ratio | 1.54 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 1.71 |
| P/OCF Ratio | 1.71 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.67, with an EV/FCF ratio of 1.48.
| EV / Earnings | 2.39 |
| EV / Sales | 0.17 |
| EV / EBITDA | 7.67 |
| EV / EBIT | n/a |
| EV / FCF | 1.48 |
Financial Position
The company has a current ratio of 0.84, with a Debt / Equity ratio of 0.17.
| Current Ratio | 0.84 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 0.96 |
| Debt / FCF | 0.19 |
| Interest Coverage | 0.04 |
Financial Efficiency
Return on equity (ROE) is -20.20% and return on invested capital (ROIC) is 9.56%.
| Return on Equity (ROE) | -20.20% |
| Return on Assets (ROA) | 0.07% |
| Return on Invested Capital (ROIC) | 9.56% |
| Return on Capital Employed (ROCE) | 0.35% |
| Weighted Average Cost of Capital (WACC) | 12.81% |
| Revenue Per Employee | 384,853 |
| Profits Per Employee | 27,440 |
| Employee Count | 905 |
| Asset Turnover | 1.96 |
| Inventory Turnover | 106.44 |
Taxes
In the past 12 months, BME:MAKS has paid 905,857 in taxes.
| Income Tax | 905,857 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.81% in the last 52 weeks. The beta is 0.91, so BME:MAKS's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | -13.81% |
| 50-Day Moving Average | 8.29 |
| 200-Day Moving Average | 8.63 |
| Relative Strength Index (RSI) | 35.19 |
| Average Volume (20 Days) | 2,352 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:MAKS had revenue of EUR 348.29 million and earned 24.83 million in profits. Earnings per share was 2.77.
| Revenue | 348.29M |
| Gross Profit | 22.17M |
| Operating Income | 186,146 |
| Pretax Income | -6.68M |
| Net Income | 24.83M |
| EBITDA | 7.73M |
| EBIT | 186,146 |
| Earnings Per Share (EPS) | 2.77 |
Balance Sheet
The company has 29.70 million in cash and 7.46 million in debt, with a net cash position of 22.24 million or 2.46 per share.
| Cash & Cash Equivalents | 29.70M |
| Total Debt | 7.46M |
| Net Cash | 22.24M |
| Net Cash Per Share | 2.46 |
| Equity (Book Value) | 44.48M |
| Book Value Per Share | 4.49 |
| Working Capital | -20.41M |
Cash Flow
In the last 12 months, operating cash flow was 40.25 million and capital expenditures -172,231, giving a free cash flow of 40.07 million.
| Operating Cash Flow | 40.25M |
| Capital Expenditures | -172,231 |
| Depreciation & Amortization | -1.36M |
| Net Borrowing | -19.85M |
| Free Cash Flow | 40.07M |
| FCF Per Share | 4.43 |
Margins
Gross margin is 6.36%, with operating and profit margins of 0.05% and 7.13%.
| Gross Margin | 6.36% |
| Operating Margin | 0.05% |
| Pretax Margin | -1.92% |
| Profit Margin | 7.13% |
| EBITDA Margin | 2.22% |
| EBIT Margin | 0.05% |
| FCF Margin | 11.51% |
Dividends & Yields
BME:MAKS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.97% |
| Shareholder Yield | -6.97% |
| Earnings Yield | 36.16% |
| FCF Yield | 58.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |